Optimisation of chemotherapy in the era of immunotherapy

Eur Respir J. 2018 Oct 25;52(4):1801698. doi: 10.1183/13993003.01698-2018. Print 2018 Oct.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • Cohort Studies
  • Humans
  • Immunotherapy
  • Lung Neoplasms*
  • Pemetrexed

Substances

  • Pemetrexed